Event | Apixaban (n = 4236) |
Enoxaparin (n = 4228) |
Absolute risk difference (Apixaban – Enoxaparin) (95% CI) |
Interaction P value |
---|---|---|---|---|
Major VTE, % (n/N) | ||||
Overall | 0.68 (23/3394) | 1.50 (51/3394) | -0.76 (- 1.23, - 0.30) | |
Body weight ≤ 60 kg | 0.25 (1/404) | 0.50 (2/400) | - 0.25 (- 1.09, 0.59) | .9335 |
Body weight > 60 kg | 0.74 (22/2878) | 1.64 (49/2988) | - 0.84 ( -1.36, -0.33) | |
Major bleeding, % (n/N) | ||||
Overall | 0.74 (31/4174) | 0.77 (32/4167) | - 0.02 (- 0.40, 0.35) | |
Body weight ≤ 60 kg | 1.24 (6/484) | 0.20 (1/497) | 1.04 (- 0.02, 2.10) | .0706 |
Body weight > 60 kg | 0.68 (25/3677) | 0.82 (30/3659) | - 0.14 (- 0.53, 0.25) | |
Major + CRNM bleeding, % (n/N) | ||||
Overall | 4.36 (182/4174) | 4.94 (206/4167) | - 0.58 (- 1.49, 0.32) | |
Body weight ≤ 60 kg | 3.10 (15/484) | 4.43 (22/497) | - 1.32 (- 3.69, 1.06) | .4433 |
Body weight > 60 kg | 4.54 (167/3677) | 4.97 (182/3659) | - 0.44 (- 1.41, 0.54) |